SCHEMBL17091592

SCHEMBL17091592

O=c1nc(-c2ccc(-c3ccc4cccc(O)c4n3)cc2)s[nH]1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ METAP2 P50579 2/20 0.39
▸ PLAU P00749 1/20 0.39
▸ NCF1 P14598 1/20 0.39
▸ PIM1 P11309 1/20 0.38
▸ PARP1 P09874 3/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ALOX12 P18054 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ PDE4D Q08499 2/20 0.38
▸ SOS2 Q07890 1/20 0.36
▸ METAP1 P53582 3/20 0.34
▸ MMP2 P08253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17091600 0.79 PARP1 (0.39) KDM4EKMT2AMETAP2PLAUNCF1
SCHEMBL17091593 0.78 NOTUM (0.48) KDM4EKMT2AMETAP2PLAUNCF1
SCHEMBL17091608 0.74 PDE4D (0.40) KDM4EKMT2AMETAP2PLAUNCF1
SCHEMBL1289527 0.74 ESR1 (0.61) AR
SCHEMBL564494 0.73 PARP1 (0.58) KDM4EKMT2AMETAP2PLAUNCF1
SCHEMBL29729655 0.73 PARP1 (0.58) KDM4EKMT2AMETAP2PLAUNCF1
SCHEMBL10049513 0.72 PLAU (0.58) KDM4EKMT2AMETAP2PLAUNCF1
SCHEMBL6662996 0.72 METAP2 (0.49) KDM4EKMT2AMETAP2PLAUNCF1
SCHEMBL29040616 0.72 PARP1 (0.57) KDM4EKMT2AMETAP2PLAUNCF1
SCHEMBL30457867 0.72 PARP1 (0.57) KDM4EKMT2AMETAP2PLAUNCF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2624695-B1 NOVEL SUBSTITUTED QUINOLINE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS NIVALIS THERAPEUTICS INC (US) 2015-09-23 — — EP claimed
Send feedback